NCT02324309View on ClinicalTrials.gov

BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

November 30, 2014

Conditions
Diabetes Mellitus
Interventions
DRUG

BIOD-531

DRUG

Humalog Mix 75/25

DRUG

Humulin R U-500

DRUG

BIOD-531

Trial Locations (1)

91911

Profil Institute for Clinical Research, Inc. (PICR), Chula Vista

Sponsors

Lead Sponsor

Biodel
All Listed Sponsors
lead

Biodel

INDUSTRY

NCT02324309 - BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance | Biotech Hunter | Biotech Hunter